Nxera Pharma Co., Ltd.
ネクセラファーマ株式会社
Valuation
Fundamental ratios for the latest reported period.
Ticker: 4565
FY2025 · 2025-12-31
| Gross margin | 72.3% |
| Operating margin | -28.6% |
| Net margin | -42.3% |
| Return on equity | -20.5% |
| Return on assets | -9.3% |
| Revenue growth (YoY) | 2.7% |
| EPS (basic) | ¥-138.8 |
| EPS growth (YoY) | — |
| Current ratio | — |
| Equity ratio | 45.3% |
| Book value / share | ¥493.98 |
| Free cash flow | -3,116 M |